From humble beginnings in 1983, Sun Pharma has grown into a leading specialty generic company worldwide and the No. 1 pharmaceutical company in India. In the U.S., we are amongst the leading specialty generic companies and are ranked No. 2 in generic dermatology by prescriptions. We have a presence in 80 countries across emerging markets, with Brazil, Mexico, Russia, Romania, and South Africa being some of the key markets. We maintain a strong footprint across Western Europe, Canada, Australia, New Zealand, Israel and Japan.
Recent Posts
- Sun Pharma introduces its global innovative drug, Ilumya® in India for treatment of moderate-to-severe Plaque Psoriasis
- FDA approves label update for UNLOXCYT™ (cosibelimab-ipdl) based on longer-term data that demonstrated improved clinical outcomes in advanced cutaneous squamous cell carcinoma (aCSCC)
- AstraZeneca and Sun Pharma partner to help patients living with Hyperkalemia in India
- Sun Pharma launches ‘#SeeBeyondSugar’ campaign on World Diabetes Day: A nation-wide initiative to raise awareness about Diabetic Retinopathy
- Sun Pharma reports Q2FY26 results
Recent Comments